News
One Year using IBDoc®, a Patients View
One Year using IBDoc®, a Patients View Read More »
Four Years of experience using IBDoc®
Four Years of experience using IBDoc® Read More »
Latest IBDoc® Publications from ECCO 2019
At this years ECCO the ECCO IBD guidelines were updated to include a statement to use fecal calprotectin (fCAL) in IBD monitoring. This means that IBD patients will do many calprotectin measurements over their disease course. At the same time as in all chronic disease the therapy follow-up is more and more done remotely decreasing
Latest IBDoc® Publications from ECCO 2019 Read More »
Three new studies using IBDoc®
Fecal calprotectin (fCAL) is a biomarker used for disease monitoring in patients suffering from intestinal bowel disease (IBD) since it correlates closely with mucosal healing. Calprotectin measuring requires patients to collect and return stool samples resulting in relatively low return rate of samples. Home-based fCAL testing may improve adherence. In this post three recent publications
Three new studies using IBDoc® Read More »
Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital
Read a recent interview with Lead Inflammatory Bowel Disease Nurse, Pearl Avery, conducted by BÜHLMANN’s UK distributor Alpha Laboratories Highlight the Article: “In the six months that we have been working with the IBDoc®, one patient was saved from hospital admission. It looked like they were having an IBD flare but the symptoms were actually
Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital Read More »
IBDoc – SwissMedtech Award Nominee
At this year’s SwissMedtech Day, BÜHLMANN was nominated to receive the Swiss Medtech Award. Switzerland is listed by key rankings as the “globally most innovative country”. Medtech one of the industries heavily contributing to this ranking. Out of 25 applications BÜHLMANN Laboratories AG was chosen to present IBDoc® to a Jury of medtech and academic
IBDoc – SwissMedtech Award Nominee Read More »
First IBD Nurse led IBDoc Study
Pearl Avery, UK IBD Nurse of the year, shares her first experience using IBDoc® in clinical practice. She explains the study she published at ECCO 2018 in Vienna in this video: By loading the video, you agree to YouTube’s privacy policy.Learn more Load video Always unblock YouTube
First IBD Nurse led IBDoc Study Read More »
IBDoc is now part of the TactioRPM
Tactio Health Group and Telia Company team up to accelerate the development of patient-centred digital health programs in Sweden and other Nordic and Baltic countries. The Swedish telecommunication company Telia, together with AbbVie Sweden, developed the IBD Home platform using the TactioRPM platform. IBD Home is a complete IBD remote monitoring ecosystem. The IBD Home app
IBDoc is now part of the TactioRPM Read More »
CALPROTECTIN TESTING GOES MOBILE
Read a recent post from Amanda Appleton, the Product Manager for Calprotectin at our UK distributor Alpha Laboratories. She ends the article with following sentence: “App technology has the ability not only to improve the health of patients but to save money through rapid optimisation of treatment, enable early interventions through monitoring before conditions get
CALPROTECTIN TESTING GOES MOBILE Read More »